019170 — SHINPOONG PHARMACEUTICAL CO Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Market Cap
KR₩584bn
Enterprise Value
KR₩575bn
Revenue
KR₩200bn

Annual balance sheet for SHINPOONG PHARMACEUTICAL CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS/A	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	66,000	190,469	92,519	55,795	60,461
Net Total Accounts Receivable
Net Total Receivables	101,833	96,779	90,368	90,718	82,103
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	219,192	338,577	232,997	196,542	198,935
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	130,942	124,177	116,884	113,760	118,638
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	380,114	492,915	398,350	361,536	350,084
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	133,953	83,337	28,550	27,167	76,385
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	171,930	113,778	39,093	31,929	80,498
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	208,184	379,137	359,257	329,607	269,586
Total Liabilities & Shareholders' Equity	380,114	492,915	398,350	361,536	350,084
Total Common Shares Outstanding
Total Preferred Shares Outstanding